Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Matthew Dankner, Gaia Griguolo et al.|The Breast|2023Cited by 25
Radiomics as an emerging tool in the management of brain metastasesAlexander Nowakowski, Matthew Dankner, Zubin Lahijanian et al.|Neuro-Oncology Advances|2022Cited by 18
A systematic review and meta-analysis of intrathecal versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.Anna-Maria Lazaratos, Matthew Dankner, Sarah M. Maritan et al.|Journal of Clinical Oncology|2023Cited by 0